The CCR4 transcriptional regulatory complex consisting of CCR4, CAF1, DBF2 and other unidentified factors is one of several groups of proteins that affect gene expression. Using mass spectrometry, we have identified the 195, 185 and 116 kDa species which are part of the CCR4 complex. The 195 and 185 kDa proteins were found to be NOT1 and the 116 kDa species was identical to NOT3. NOT1, 2, 3 and 4 proteins are part of a regulatory complex that negatively affects transcription. All four NOT proteins were found to co-immunoprecipitate with CCR4 and CAF1, and NOT1 co-purified with CCR4 and CAF1 through three chromatographic steps in a complex estimated to be 1.2ϫ10 6 Da in size. Mutations in the NOT genes affected many of the same genes and processes that are affected by defects in the CCR4 complex components, including reduction in ADH2 derepression, defective cell wall integrity and increased sensitivity to monoand divalent ions. Similarly, ccr4, caf1 and dbf2 alleles negatively regulated FUS1-lacZ expression, as do defects in the NOT genes. These results indicate that the NOT proteins are physically and functionally part of the CCR4 complex which forms a unique and novel complex that affects transcription both positively and negatively.
Introduction
There are a number of general regulatory complexes that are involved in transcriptional processes. For example, in addition to the yeast holoenzyme that contains the SRB proteins (Wilson et al., 1996) , the SPT3-ADA2-GCN5 complex (Grant et al., 1997) , the NOT complex (Collart and Struhl, 1994) , the PAF1 holoenzyme (Wade et al., 1996) and the CCR4 complex have all been identified as playing roles in affecting gene transcription. Each of these groups of proteins appears to be unique. The interaction and functional relationship of these groups of transcriptional regulatory factors, however, remain to be clearly established. In this study, we demonstrate that the NOT protein complex is part of the CCR4 transcriptional 1096 © Oxford University Press complex and that these two groups of proteins share overlapping functions.
CCR4 affects the expression of many genes and processes in yeast. It is required for the expression of ADH2 and other non-fermentative genes (Denis, 1984; Denis and Malvar, 1990) and for unidentified genes involved in cell wall integrity . ccr4 mutations result in a partial cell cycle block during telophase and increase the sensitivity of yeast cells to Li ϩ and Mg 2ϩ . ccr4 is also a suppressor of spt10 mutations (Denis, 1984) , defects which result in enhanced transcription at ADH2 (Denis and Malvar, 1990 ) and other loci (Natsoulis et al., 1991) . In addition to acting as an activator, CCR4 has been implicated in negatively affecting gene expression as well (McKenzie et al., 1993; Schild, 1995) . CCR4 is a component of a multi-subunit complex . Two of the CCR4 complex components, CAF1 (POP2) (Sakai et al., 1992; Draper et al., 1995) , and DBF2, a cell cycle-regulated protein kinase (Toyn et al., 1991) , function to control many of the same processes as CCR4 . While none of these genes by themselves are essential, the phenotypes conferred by the ccr4, caf1 and dbf2 mutations indicate that the CCR4 complex is required for optimal and proper expression of many genes. The evolutionary conservation of CAF1 across eucaryotes (Draper et al., 1995) further suggests that this complex plays an important role in eucaryotic gene control. Although the mechanism of how CCR4 functions remains unclear, the site of CCR4 action at the ADH2 locus has been shown to occur at a post-chromatin remodeling step (Verdone et al., 1997) .
In addition to CAF1 and DBF2, the CCR4 complex contains several unidentified proteins, 195, 185, 140 and 116 kDa in size . Our initial attempt at cloning the corresponding genes for these proteins by two-hybrid analysis was unsuccessful (Draper et al., 1995; Liu et al., 1997) . Mass spectrometry has recently become the method of choice for rapid and unambiguous identification of gel-separated proteins. Large-scale analysis of yeast proteins is now possible , and entire yeast protein complexes can be studied (Lamond and Mann, 1997; Neubauer et al., 1997) . Here, we have used these methods to identify the 195, 185 and 116 kDa species of the CCR4 complex. The 185 and 195 kDa species were found to be NOT1 and the 116 kDa species was found to be NOT3.
The NOT genes have been identified as encoding a group of factors involved in repressing the transcription of HIS3 from a non-canonical TATA (Collart and Struhl, 1994) . This group of proteins contains NOT1/CDC39, NOT2/CDC36, NOT3 and NOT4/MOT2/SIG1, and genetic evidence indicates that they function as a complex in vivo (Collart and Struhl, 1993, 1994) . In addition to affecting HIS3 expression, the not mutations augment the Fig. 1 . Immunoprecipitation of the CCR4 complex for protein sequencing by mass spectrometry. The yeast whole cell extracts containing either LexA alone or full-length LexA-CAF1 were treated with the LexA antibody, and the resulting immunoprecipitates were subjected to SDS-PAGE. The resulting gel was stained with Coomassie blue. 'M' indicates the molecular weight standard. Lanes 1 and 2 are the immunoprecipitates from extracts containing LexA alone and LexA-CAF1, respectively. The 195, 185 and 116 kDa species in lane 2 were excised prior to mass spectrometric analysis. expression of many genes or reporter genes, confirming their role as a repression complex (Cade and Errede, 1994; Collart and Struhl, 1994; Irie et al., 1994; Collart, 1996) . Of the four NOT genes, only NOT1 was found to be essential. We have subsequently shown that NOT2 and NOT4 also associate with the CCR4 complex. Genetic analyses reveal that NOT defects result in phenotypes similar to those observed with the deletion of CCR4 and its associated components. These results indicate that the CCR4 complex includes the NOT proteins and that this complex can affect gene transcription both positively and negatively.
Results
The 185/195 and 116 kDa proteins in the CCR4 complex are NOT1 and NOT3 To identify the proteins which associate with CCR4, the CCR4 complex was isolated by immunoprecipitation. Yeast extracts, containing either a LexA-CAF1 fusion protein or just LexA alone, were incubated with an antibody directed against the LexA protein, and the resulting immunoprecipitates were subjected to SDS-PAGE (Figure 1 ). After staining the proteins, the 116, 185 and 195 kDa species that specifically co-immunoprecipitated with CCR4 were isolated and were analyzed by mass spectrometry using the strategy previously described . A small aliquot of the peptide mixture resulting from in-gel digestion of the bands was analyzed by matrix-assisted laser desorption/ionization (MALDI). High resolution peptide mass maps were obtained of all three bands which were analyzed. Database searches with the set of measured masses resulted in the following identifications: band 116 kDa was NOT3, band 185 kDa was NOT1 and band 195 kDa was also NOT1. The identification of NOT3 was performed by MALDI peptide mapping only. The database search revealed that 26 measured peptide masses fit the sequence of NOT3 within a mass accuracy of 50 p.p.m. This corresponds to 30% of the sequence. The other two bands were subjected to both MALDI peptide mapping and mass spectrometric sequencing using nanoelectospray . The peptide maps covered 29% of the protein in the band migrating at 185 kDa and 32% of the protein in the band migrating at 195 kDa. The identification of the lower band is shown in Figure 2 . Sequencing of 10 of the peptides derived from the 185 kDa band and eight of the peptides derived from the 195 kDa band confirmed the identification (data not shown). No peptides of the N-terminal region of the NOT1 protein were found in the analysis of the lower band. Thus, the data are consistent with the N-terminal truncation of the NOT1 protein suggested by previous studies (Collart, 1996) . NOT2 and NOT4 are also in the CCR4 complex The NOT1 and NOT3 proteins have been shown to be part of a complex that also includes the NOT2 and NOT4 proteins (Collart and Struhl, 1994) . To examine the possibility that the NOT2 and NOT4 proteins were also part of the CCR4 complex, we carried out a series of immunoprecipitation experiments. We first examined the association of NOT1 with CCR4. A LexA-NOT1 fusion was expressed in a wild-type strain. LexA-NOT1 was immunoprecipitated with the LexA antibody while the CCR4 complex was immunoprecipitated with the CCR4 antibody. The resulting immunoprecipitates were subjected to Western blot analysis ( Figure 3A ). CCR4 co-immunoprecipitated with LexA-NOT1 ( Figure 3A , lane 3) while LexA-NOT1 along with the NOT1 proteins (185/195 kDa) were co-immunoprecipitated with CCR4 ( Figure 3A , lane 5). These results confirm the protein sequencing data.
To investigate the association of NOT2 with the CCR4 complex, a LexA-NOT2 fusion was expressed in a wildtype strain, a ccr4Δ strain and a caf1Δ strain. An antibody raised against the LexA protein was used to immunoprecipitate the LexA-NOT2 fusion while antibodies raised against either CCR4 or CAF1 were used to bring down CCR4 and CAF1, respectively. The resulting immunoprecipitates were subjected to SDS-PAGE, followed by Western blot analysis ( Figure 3A and B). Immunoprecipitating LexA-NOT2 with the LexA antibody resulted in co-immunoprecipitation of NOT1 from the wild-type, ccr4Δ and caf1Δ extracts ( Figure 3A , lane 4, and B, lanes 1 and 2, respectively). CCR4 co-immunoprecipitated along with LexA-NOT2 and NOT1 from the wild-type strain ( Figure 3A , lane 4), but not from the caf1Δ strain ( Figure 3B , lane 1). When the CCR4 antibody was used to repeat the immunoprecipitation experiments, the NOT1 and LexA-NOT2 proteins were found to co-immunoprecipitate with CCR4 from the wild-type strain ( Figure 3A , lane 6), but not from the strains lacking either CAF1 ( Figure 3B , lane 3) or CCR4 ( Figure 3B , lane 4). Longer exposures of the results presented in Figure 3B , lane 3, indicated that a small amount of NOT1 and LexA-NOT2 was found to co-immunoprecipitate with CCR4 from the caf1Δ strain (data not shown). These results indicate that NOT2 physically interacts with both CCR4 and NOT1, and that the association of CCR4 with the NOT proteins is largely dependent on the presence of 
CAF1.
The immunoprecipitation experiments were also repeated by using the CAF1 antibody. NOT1, LexA-NOT2 and CCR4 were found to co-immunoprecipitate with CAF1 from the wild-type strain (data not shown), and NOT1 and LexA-NOT2 were co-immunoprecipitated with CAF1 from the ccr4Δ strain ( Figure 3B , lane 6). However, NOT1 and LexA-NOT2 failed to co-immunoprecipitate with the CAF1 antibody from the caf1Δ strain ( Figure 4B , lane 7), confirming that LexA-NOT2 does not immunoprecipitate fortuitously with the CAF1 antibody. These results also suggest that the interaction between CAF1 and the NOT proteins is CCR4 independent.
To address the question as to whether NOT4 was in the CCR4 complex, a c-Myc-tagged NOT4 fusion was expressed along with LexA-CAF1 in a wild-type strain. Extracts treated with the LexA antibody resulted in coimmunoprecipitation of c-Myc-NOT4 with LexA-CAF1, CCR4 and NOT1 ( Figure 4A , lane 3), while the LexA preimmune serum failed to immunoprecipitate these proteins ( Figure 4A, lane 2) . The c-Myc-NOT4 protein also coimmunoprecipitated with CCR4 and NOT1 when the extracts were immunoprecipitated with either CAF1 antibody ( Figure 4A , lane 4) or CCR4 antibody ( Figure 4A , lane 5). Immunoprecipitation with the c-Myc antibody, in turn, was able to bring down LexA-CAF1, CCR4 and NOT1 along with c-Myc-NOT4 (lane 6). We also immunoprecipitated the CCR4 complex from an extract prepared from a strain expressing both LexA-NOT2 and c-Myc-NOT4 fusion proteins. The resulting immunoprecipitates were analyzed by Western blot ( Figure 4B ). It is clear that NOT1, NOT2 and NOT4 co-immunoprecipitated with CCR4 and CAF1. Because NOT3 is also in the CCR4 complex as determined by mass spectrometry, we conclude that the complete NOT repressive regulatory complex is part of the CCR4 complex.
Two-hybrid analysis was used further to examine the interaction of the NOT proteins and the CCR4 complex components. As shown in Table I , both B42-NOT1 and B42-NOT2 interacted with LexA-CAF1, and LexA-NOT1 was found to interact with B42-CAF1. LexA-CCR4 interacted with B42-NOT1, and B42-DBF2 interacted well with LexA-NOT2. The multiplicity of these interactions confirms the above-described protein analyses.
The CCR4 complex is a unique transcriptional regulatory complex Our previous studies on CCR4 indicated that the CCR4 complex is a transcriptional regulatory complex distinct from that of several other complexes such as the SNF/ SWI complex, the yeast holoenzyme and the putative SPT4, 5, 6 complex . The size of the CCR4 complex was estimated following Superose 6 gel filtration chromatography. As shown in Figure 5A , CCR4 migrated in two separate peaks of 1.9ϫ10 6 and 1.0ϫ10 6 Da. In other experiments, a small portion of CCR4 migrated at 2.0ϫ10 5 Da, which is close to the size of CCR4 and may represent monomeric CCR4 ( Figure 5C , top panel). The two larger complexes were also unaffected by prior DNase treatment, suggesting that they do not result from non-specific binding to DNA ( Figure 5A , data The yeast whole extracts containing LexA-NOT2 prepared from a caf1-deleted strain (lanes 1, 3 and 5) or a ccr4-deleted strain (lanes 2, 4 and 6) were treated with LexA antibody (lanes 1 and 2), CCR4 antibody (lanes 3 and 4) or CAF1 antibody (lanes 5 and 6). The resulting immunoprecipitates were subjected to immunoblot analysis and probed with NOT1, CCR4 and LexA antibodies. The bands beneath LexA-NOT2 in lanes 1 and 2 represent degradation products of LexA-NOT2 (data not shown).
not shown). The 1.9ϫ10 6 Da CCR4 complex is separate from that of the SRB complex which, as analyzed on a longer Superose 6 column, migrated at 1.7ϫ10 6 Da ( Figure 5B ). Moreover, in a caf1Δ strain, most of the CCR4 protein was found at the 1.0ϫ10 5 Da size, indicating that the CAF1 protein is required for CCR4 association in the 1.9ϫ10 6 and 1.0ϫ10 6 Da complexes ( Figure 5C , top two panels). A caf1Δ had no effect, however, on the ability of the non-CCR4 complex component, SPT10, to migrate at 1.9ϫ10 6 Da ( Figure 5C , bottom two panels), LexA-CCR4, -NOT1 and -NOT2 contain full-length CCR4, NOT1 and NOT2. LexA-CAF1 contains residue 127-444 of CAF1. All LexA fusions contain residues 1-202 of LexA. B42-NOT1, -NOT2 and -DBF2 contain full-length NOT1, NOT2 and DBF2. B42-CAF1 contains residues 148-444 of CAF1. -indicates the β-galactosidase activity is no greater than the background interaction with B42 alone. Yeast whole cell extracts were chromatographed on an extended Superose 6 HR16/50 column. The resulting 1 ml fractions (first 12 fractions) were subjected to immunoblot analysis and probed with CCR4 and SRB5 antibodies. The arrow indicates the peak containing SRB5. (C) Yeast whole cell extracts prepared from a wild-type or a caf1-deleted strain were chromatographed on the Superose 6 HR10/30 column. The resulting 1 ml fractions (every other fraction is displayed) were subjected to immunoblot analysis and probed for CCR4 (top two panels) and SPT10 (bottom two panels). 'CAF1' and 'caf1' indicate the wild-type and caf1-deleted strains, respectively. The 120 kDa band that runs above CCR4 in the CCR4-probed panel represents a non-specific protein and serves as an internal control for the experiment. Based on this control, the amount of protein loaded for the 'CAF1' experiment was about twice that of the 'caf1' experiment, resulting in the decreased level of CCR4 protein visible in the 'caf1'experiment for the SPT10 Western (bottom panel).
nor on the SRB5 protein to migrate at 1.7ϫ10 6 Da (data not shown).
To analyze the CCR4 complex further, we isolated the CCR4 complex from a strain in which the CAF1 gene was deleted and a CAF1 gene tagged at its C-terminus with 6ϫHis was integrated into the genome at the TRP1 locus. This CAF1-6His gene was able to complement the defect of caf1Δ . The extracts prepared from this strain were first put onto a Ni 2ϩ -NTA column, and the bound proteins was eluted with 250 mM imidazole. The NOT1 protein and CAF1-6His were found to coimmunoprecipitate with CCR4 when the Ni 2ϩ eluate was treated with CCR4 antibody (data not shown). The Ni 2ϩ eluate subsequently was loaded onto a Mono Q column, and the bound proteins were eluted in a linear salt gradient. Yeast whole cell extracts prepared from a caf1-deleted strain containing CAF1-6His integrated at the TRP1 locus were chromatographed on a Ni 2ϩ -NTA, Mono Q and Superose 6 HR10/30 column as described in Materials and methods. Fractions of 0.5 ml from the Superose 6 chromatography were subjected to immunoblot analysis and probed for NOT1, CCR4 and CAF1. The Mono Q lane refers to the peak fraction following Mono Q chromatography that was applied to the Superose 6 column. The Ni 2ϩ -NTA eluate was not probed for NOT1. The arrow indicates the size of the peak eluted from the Superose 6 column that contains NOT1, CCR4 and CAF1-6His.
The Mono Q fractions were analyzed by Western blot using both CCR4 and CAF1 antibody, and CCR4 and CAF1-6His were found to co-elute Figure 6 ). Fractions containing both CCR4 and CAF1 were pooled and the proteins were analyzed further by Superose 6 gel filtration chromatography. The fractions from these different steps in purification were subjected to Western blot analysis. The purified CCR4 complex displayed a molecular weight of 1.2ϫ10 6 Da following the Superose 6 gel filtration chromatography (Figure 6 ), corresponding closely to the 1.0ϫ10 6 Da CCR4 complex observed in crude extracts ( Figure 5A ). NOT1, CCR4 and CAF1 were all found to co-purify through these three purification steps. In contrast, Western blot analysis using antibodies against SRB5 and SRB6 failed to detect either of these proteins in the Mono Q and Superose 6 fractions (data not shown). These data indicate that NOT1, CCR4 and CAF1 are components of the same complex. In addition, the 1.9ϫ10 6 and 1.2ϫ10 6 Da CCR4 complexes appear distinct from the yeast holoenzyme containing the SRB complex.
Mutations in the NOT genes result in similar phenotypes to those observed with ccr4 and caf1 alleles The presence of the NOT proteins in the CCR4 complex suggest that they should function to control similar genes and processes as do CCR4 and its associated components. However, the NOT proteins have been characterized as a repression complex and CCR4 is generally considered to be an activator. To address this issue, we analyzed the effect of not mutations on several processes known to be affected by ccr4. The results from the phenotypic analyses are summarized in Table II . Mutations in the NOT genes except for NOT3 reduced ADH2 expression under nonfermentative conditions, indicating that the NOT proteins can act as activators. A not4 allele was also capable of suppressing the enhanced ADH2 expression that is caused 
Growth was scored on YD plates as supplemented with 8 mM caffeine, 1 mg/ml of staurosporine (stauro), 750 mM MgCl 2 or 1 M sorbitol as indicated. 3AT: growth was scored on minimal plates lacking histidine and containing 20 mM 3-aminotriazole (3AT) using strains isogenic to KY803 (wt) containing the YCp88-Sc4363 plasmid (Collart and Struhl, 1994) . Strains used for monitoring caffeine, Mg 2ϩ , temperature and staurosporine sensitivity were KY803 (wt), EGY188-1 (ccr4), EGY188-c1 (caf1), MY8 (not1), MY16 (not2), MY508 (not3) and MY537 (not4). Wild-type strain EGY188 gave the same results as KY803. ADH II activities (mU/mg) represent the average of at least three determinations and were conducted following growth at 30°C on YEP medium containing 3% ethanol. No effect was observed in the not mutations on ADH II activity under glucose growth conditions (data not shown). The SEM for the ADH II activities was Ͻ20%. For ADH II assays, the following strains were used: wt, KY803-Δ3; not1, MY8-Δ1; not2, MY16-Δ1; not3, MY25-Δ1; not4, 612-1d-n4; and for spt10 ADH II assays the strains were: wt, spt10 segregants from cross 808-5c and 612-1d-n4; not1, spt10 not1-2 segregants from cross MY8Δ1 and 1366-4a; not2, spt10 not2 segregants from cross 808-5c and MY16-Δ1; not4, spt10 not4 segregants from cross 808-5c and 612-1d-n4. The isogenic parent for 612-1d-n4 is 612-1d whose ADH II activity is 3000 mU/mg. ADH II and spt10 ADH II activities for ccr4 and caf1 strains are taken from Denis (1984) and Draper et al. (1995) . N.D., not done; 'ϩ', good growth; 'w', weak growth; '-', no or poor growth.
by an spt10 defect. All of the not alleles except for not3 also displayed sensitivity to caffeine, a phenotype resulting from defects in cell wall integrity, which is shared by the ccr4, caf1 and dbf2 alleles . ccr4, caf1 and dbf2 mutations also result in temperature-and/or coldsensitive phenotypes that are suppressible by 1 M sorbitol, confirming their roles in control of cell wall integrity . In agreement with this phenotype, it has been shown previously that a not4 allele confers a temperaturesensitive phenotype that is suppressible by 1 M sorbitol (Cade and Errede, 1994) . We subsequently found that the not2 ts phenotype was also relieved by 1 M sorbitol (Table II) . Also, the caffeine-sensitive phenotype of not4 was suppressed by 1 M sorbitol (data not shown). In agreement with these results, not2, not3 and not4 alleles were sensitive to staurosporine, an inhibitor of PKC1, indicative of cell wall defects. Moreover, not1, not2 and not4 alleles were sensitive to 0.04% SDS, another phenotype indicative of a defect in cell wall integrity (Igual et al., 1996) also displayed by ccr4, caf1 and dbf2 alleles (data not shown). Furthermore, not1, not2 and not4 alleles were sensitive to high concentrations of the divalent cation, Mg 2ϩ , as are ccr4-, caf1-and dbf2-containing strains (Table II) . These results indicate that defects in the NOT factors result in phenotypes consistent with the NOT proteins functioning in processes similar to CCR4, CAF1 and DBF2.
The CCR4 complex has positive and negative effects on gene transcription
To address whether the CCR4 complex components can act as repressors in a manner similar to that observed for the NOT proteins, we examined the effect of ccr4, caf1 and dbf2 defects on FUS1-lacZ expression. Mutations in NOT genes result in increased expression of the FUS1 gene or the FUS1-lacZ reporter gene in the absence of pheromone stimulation (Cade and Errede, 1994; Collart and Struhl, 1994; Irie et al., 1994) . As shown in Figure 7A , deletion of CAF1 caused a 5-fold increase in β-galactosidase activity from the FUS1-lacZ reporter, while deletion of 1101 CCR4 and DBF2 resulted in an increase of β-galactosidase activity of~2-and 3-fold, respectively. These results are similar to the 2-to 5-fold effects observed for the not effects on the FUS1 promoter. The ccr4, caf1 and dbf2 effects on the FUS1-lacZ reporter were specific to the FUS1 promoter since ccr4, caf1 and dbf2 had very different effects on other lacZ reporters carrying different promoters (see below).
To extend the comparison of the NOT proteins and the CCR4 complex components, we examined the effects of their mutations on several other reporter genes. All reporter genes, including the FUS1-lacZ reporter, are derived from a UAS-less lacZ reporter. As shown in Figure 7B , mutations in the NOT genes, CCR4 and CAF1 resulted in decreased expression of the CYC1-lacZ reporter gene (dependent on the HAP2, 3, 4 and 5 activator complex), in which the ccr4, caf1 and not2 alleles had the greatest effects. The effect on CYC1-lacZ expression was more severe when cells were supplied with a non-fermentable carbon source, such as ethanol and glycerol, than with glucose, but ccr4, caf1 and not3 also had effects under glucose growth conditions. The observed effects on the derepressed expression of the CYC1-lacZ reporter was not due to general effects on the plasmid or lacZ expression since the FKS1-lacZ reporter was largely unaffected under non-fermentative growth conditions by these same mutations ( Figure 7C ). These data confirm that, as observed with effects on ADH2 expression, the NOT genes can also be involved in the activation of gene transcription.
Though the NOT genes and CCR4 behave similarly, some variations in their effects on gene transcription were observed when we examined other lacZ reporter genes. In the case of HO-lacZ expression, not1, not2, not4 and dbf2 defects increased β-galactosidase activity while the strains containing deletion of ccr4, caf1 or not3 showed reduced β-galactosidase activity ( Figure 7C ). When the FKS1-lacZ reporter was examined, variation in the effects was again observed. The not1, not4 and dbf2 alleles caused 2-fold increases in β-galactosidase activity, while either ccr4 or not3 caused reductions in β-galactosidase activity Fig. 7 . Effects of the ccr4, caf1, dbf2 and not mutations on regulation of gene expression. (A) β-Galactosidase activity in strains (grown on minimal medium lacking uracil and supplemented with 8% glucose) carrying a plasmid-borne FUS1-lacZ reporter gene without pheromone stimulation. Values are averages for at least five transformants, and the standard error of the mean (SEM) was Ͻ20% except for strain EGY188 in which it was 35%. wt, EGY188; dbf2, EGY188-d2; ccr4, EGY188-1-1; and caf1, EGY188-c1-1. (B) β-Galactosidase activity in strains carrying a plasmid-borne CYC1-lacZ reporter, LG265UP1, containing the upstream element for the HAP2, 3, 4 and 5 activator (Guarente and Mason, 1983) . The upper panel displays the effects of ccr4, caf1 and dbf2 mutations on the expression of the CYC1-lacZ reporter while the lower panel gives the effects of the not mutations on expression of the same reporter. Values are averages for at least four transformants, and the SEM was Ͻ25% for glucose-grown culture whereas, for non-fermentative culture the SEM was Ͻ30%, except for strains EGY188-1-1 and EGY188-c1-1 in which it was Ͻ50%. Strains used for the upper panels for (B), (C) and (D) are the same as (A), and for the lower panels strains are: wt, KY803; not1, MY8; not2, MY16; not3, MY25; and not4, MY20. (C and D) The same experiments as (B) except that the CYC1-lacZ reporter was replaced by either a HO-lacZ reporter [containing the complete upstream sequence of the HO gene, plasmid BA161 (Breeden and Nasmyth, 1987 )] (C) or a FKS1-lacZ reporter (plasmid pF712-380, Igual et al., 1996) (D) . Values are averages for at least three transformants, and the SEM was Ͻ25%.
( Figure 7D ). The not2, and caf1 alleles showed less dramatic or no effects on FKS1-lacZ expression. These results indicate that different components of the CCR4 complex have similar but not necessarily identical effects on gene expression.
We also analyzed the effect of caf1 and ccr4 defects on HIS3 gene expression under conditions when the GCN4 activator is disabled. Using strain KY803, in which not mutations cause resistance to 20 mM 3-aminotriazole (3AT) whereas the parent strain is sensitive (Collart and Struhl, 1994) (Table II) , we deleted CCR4 and CAF1. A ccr4 disruption in this strain background did not result in any enhanced HIS3 expression and resistance to 20 mM 3AT whereas a caf1 disruption resulted in weak growth at 20 mM 3AT, indicative of a slight increase in HIS3 expression (Table II) .
Discussion
The NOT negative regulatory complex is physically associated with the CCR4 transcriptional regulatory complex Using mass spectrometry, we have identified the 195, 185 and 116 kDa species of the CCR4 complex. The 195 and 185 kDa species were found to be NOT1 and the 116 kDa species was found to be NOT3. The 185 kDa species is an apparent degradation product of NOT1 and is missing 100 amino acids from the N-terminus. The 195 and 185 kDa species were also shown to react specifically with an antibody raised against a GST-NOT1 fusion protein. The NOT1 and NOT3 proteins are part of the NOT negative regulatory complex containing four proteins (NOT1, NOT2, NOT3 and NOT4) (Collart and Struhl, 1994) . We subsequently showed by co-immunoprecipitation that the NOT2 and NOT4 proteins were also associated with the CCR4 complex. The interactions between the NOT proteins and the CCR4 complex were also confirmed by two-hybrid analysis (Table II) . These results imply that there exist multiple interactions among these components and provide additional evidence that NOT proteins are part of the CCR4 complex. Recently, another component of the NOT complex, the NOT5 protein, has been found to be functionally and physically associated with the other NOT proteins (Oberholzer and Collart, 1998) . We have since shown that NOT5 also specifically co-immunoprecipitates with CCR4 and CAF1 ( Figure 4B ; data not shown), suggesting that it too is part of the CCR4-NOT complex.
We also showed that NOT1, CCR4 and CAF1 copurified through three different chromatographic steps using a CAF1-6His fusion to aid in the isolation of the CCR4 complex. This purified CCR4 complex containing the CAF1-6His fusion was eluted from a Superose 6 column with an estimated mol. wt of 1.2ϫ10 6 Da. During the purification, the majority of CCR4 was found to be associated with CAF1-6His. Determination of the size of the CCR4 complex by gel filtration from a wild-type strain indicated that CCR4 and CAF1 were part of large complexes with estimated mol. wts of 1.9ϫ10 6 and 1.0ϫ10 6 Da. We have not been able to isolate the 1.9ϫ10 6 Da CCR4 complex using the 6His-tagged CAF1 or CCR4, partly as the result of reduced levels of the 1.9ϫ10 6 Da complex in these strains (unpublished observations). It is also possible that we would not be able to isolate the larger CCR4 complex using the methodology employed in this report.
These findings confirm that the CCR4 complex is truly a multi-subunit complex. The immunoprecipitation results, the co-purification of NOT1 with the CCR4 complex, the two-hybrid analysis and the previous studies on the NOT complex strongly implicate the NOT2, 3 and 4 proteins as being components of the 1.2ϫ10 6 Da CCR4 complex, which can be considered the core CCR4-NOT complex. It remains possible, however, that other forms of the NOT complex may exist, especially since a previously identified NOT complex was found to be only 6ϫ10 5 Da in size (Collart and Struhl, 1994) .
By several criteria, the CCR4 complexes appear distinct from the yeast holoenzyme. First, neither CCR4 nor CAF1 were found to be in purified preparations of the yeast holoenzyme (Draper et al., 1995) . Second, SRB5 migrated in a complex that was slightly smaller than the 1.9ϫ10 6 Da CCR4 complex ( Figure 5B ). Third, SRB proteins did not co-purify with the 1.2ϫ10 6 Da complex. A number of other proteins were checked for their presence in the 1.2ϫ10 6 Da complex or for their ability to coimmunoprecipitate with CCR4 or CAF1. RPB1, MOT1, SPT6, SPT10, ADA2, SIN3, SIN4 and several SNF/SWI proteins were all shown not to be part of the CCR4 complex (Denis et al., 1994, unpublished observations) . These results place the CCR4 complex, containing the NOT proteins, as a unique and novel transcriptional regulatory group of proteins.
The role of the CAF1 protein in this complex was elucidated partly through the analysis of the effects of caf1 defects on the association of CCR4 protein with the complex. Disruption of caf1 effectively removed CCR4 protein from the 1.9ϫ10 6 and 1.2ϫ10 6 Da complexes. Correspondingly, CCR4 did not immunoprecipitate well with the NOT proteins in a caf1 background. In contrast, a ccr4 disruption did not affect CAF1 immunoprecipitation with the NOT proteins ( Figure 3B ) nor did it affect CAF1 association in the 1.9ϫ10 6 Da complex (unpublished observation). These data indicate that CCR4 association in the complex depends on the presence of CAF1. Consistent with this conclusion is the observation that high copy expression of CCR4 can complement a caf1 defect (Hata et al., 1997) ; increased levels of CCR4 would be able to associate by mass action in the CCR4 complex even in the absence of CAF1. High copy expression of CAF1 cannot complement a ccr4 defect (Hata et al., 1997) , however, apparently because CCR4 plays an essential role that increased levels of CAF1 cannot duplicate.
The NOT complex is functionally associated with the CCR4 complex
The previous studies on the NOT genes clearly demonstrated that they played a negative regulatory role in gene transcription. Our finding that this complex physically associates with the CCR4 complex would suggest that it should also be positively involved in gene transcription. By examining the defects of the NOT genes on ADH2 expression, we were able to demonstrate that mutations in the NOT genes, with the exception of NOT3, caused a reduction of ADH2 gene expression under glucosederepressed conditions. This result not only establishes functional similarity between the NOT proteins and those in the CCR4 complex but also suggests that the NOT complex is involved in activation of gene transcription.
A positive role for the NOT complex in gene transcription was demonstrated further by the observation that a not4 disruption suppressed the ability of an spt10 mutation to cause enhanced ADH2 expression under glucose growth conditions. The only other known alleles which confer this phenotype are ccr4, caf1 and dbf2, all components of the CCR4 complex . Moreover, the expression of the CYC1-lacZ reporter gene, containing the upstream binding site for the HAP2, 3, 4 and 5 proteins, was reduced by defects in the NOT genes. In this case, the defects in the NOT genes reduced CYC1-lacZ expression as did defects in CCR4 and CAF1. This reduction of CYC1-lacZ expression by the not alleles occurred primarily under non-fermentative growth conditions. Like CCR4 and CAF1, the NOT proteins may play a special role in aiding the expression of nonfermentative genes.
In addition to their similar effects on non-fermentative gene expression, the CCR4 complex components and the NOT proteins shared other phenotypic similarities. Mutations in all of these genes except that of NOT3 resulted in increased caffeine sensitivity. This phenotype appears to be the result of impaired formation of the cell wall (Levin and Bartlett-Heubusch, 1992) . Moreover, the cold-sensitive phenotype of ccr4 and the ts phenotypes of dbf2, caf1, not2 and not4 were all suppressed by osmotic stabilizing agents such as sorbitol, confirming a defect caused by the alleles in terms of cell wall integrity. ccr4, caf1, dbf2, not2, not3 and not4 alleles were also sensitive to staurosporine, indicative of a cell wall integrity problem. Increased sensitivity to mono-and divalent cations is also a phenotype associated with ccr4, caf1 and dbf2 alleles, and a similar sensitivity was observed for the not alleles.
Whereas the CCR4 complex previously had been ascribed a positive role in gene expression, its association with the NOT proteins implicates them in affecting gene expression in a negative way as well. Previous data have indicated that ccr4 mutations can negatively affect gene expression in the methionine biosynthetic pathway (McKenzie et al., 1993) . In this case, a ccr4 mutation acted in a manner similar to such other negative regulators as SPT21, RPD3 and RPD1 (SIN3). Also, ccr4 and caf1 alleles cause increased resistance to X-ray radiation, presumably by releasing negative control of genes involved in the RAD51 and RAD52 pathway (Schild, 1995) . Furthermore, the original identification of a caf1 mutation (pop2) involved its negative control of PGK1 expression during stationary phase (Sakai et al., 1992) . We further showed that CCR4, CAF1 and DBF2 negatively affect FUS1-lacZ expression in the same manner as did the NOT genes (Cade and Errede, 1994; Collart and Struhl, 1994) . These observations indicate that the CCR4 complex components, like the NOT proteins, can play negative roles in controlling gene expression. Therefore, the protein association of the NOT proteins with components of the CCR4 complex results in overall similar control of gene expression and other processes.
Notwithstanding the above-described similarities, the CCR4, CAF1, DBF2 and NOT genes were found to differ in their effects in some cases. This was observed most obviously with the HO-lacZ and FKS1-lacZ reporter genes and with HIS3 expression. These data suggest that although all the CCR4 complex components can share common functions, the individual components of this complex can behave differently in regulating different genes.
The fact that these various proteins can affect expression both positively and negatively suggests that the role of CCR4, CAF1 and the associated NOT proteins may be more versatile than previously indicated. The demonstration that CCR4 acts at the ADH2 locus at a post-chromatin remodeling step (Verdone et al., 1997) is consistent with the model that the NOT proteins act to regulate TATA box-binding protein (TBP) use of non-consensus TATAA sequences (Collart and Struhl, 1994; Collart, 1996) . The function of the CCR4-NOT complex is also clearly affected by the sequences that lie upstream of the TATAA (Figure 7) . It is likely that sequence-specific activator binding or chromatin structure influences the NOT proteins and other CCR4 complex components in their mode of action. Because of the size of the CCR4 complex and the number of its components, it is highly likely that individual factors, while showing overall functional similarity to other components in the complex, will play somewhat different roles in transcription. Individual proteins may be the targets of different regulatory factors and regulatory processes. For instance, DBF2 is a cell cycle-regulated protein kinase, and defects in DBF2 cause a telophase block. CAF1 and CCR4 are themselves not cell cycle regulated, and mutations in them cause only a partial late mitotic defect . Clearly, the CCR4 transcriptional complex does not act by itself, and identifying its contacts with the several other known protein complexes involved in transcription remains a major focus to understanding how the CCR4 complex and its individual proteins function.
Materials and methods

Strains and culture
Yeast strains are listed in Table III . Growth on YD solid medium was done with Petri plates containing YEP (1% yeast extract and 2% bactopeptone) supplemented with 2% glucose and 2% bactoagar. β-Galactosidase assays were conducted as described on minimal medium lacking uracil that was supplemented either with 8% glucose or with 2% each of glycerol and ethanol. ADH II assays were conducted as described .
Immunoprecipitation
Immunoprecipitations were carried out as described previously Liu et al., 1997) . To isolate the CCR4 complex for protein sequencing, yeast whole cell extracts prepared from a 400 ml overnight culture were mixed with 20 μl of affinity-purified LexA antibody for 45 min. To this was added 300 μl of a 50% protein A-agarose slur, and the incubation was continued for an additional 30 min. The resulting immunoprecipitate was resuspended in 150 μl of 2ϫ SDS sample buffer and boiled for 5 min. The sample was divided and loaded onto three lanes. After electrophoresis, the gel was stained in Coomassie blue solution for 2 h and destained overnight. The protein bands of interest were excised and subjected to mass spectrometric analysis. Immunoblot analysis was carried out according to the described procedures . The immunoblot results were analyzed by an Arcus II Scanner (Agfa-Gevaert, N.V., UK) and Adobe Photoshop 3.0 (Adobe Systems Inc., USA).
Protein identification by mass spectrometry
Techniques and strategy of analysis were as previously described . Gel pieces were washed, 'in-gel' reduced, Salkylated, and protein enzymatically degraded with trypsin as described . After 3 h,~2% of the digest product was applied on a micro-crystalline layer-a mixture of α-cyano-4-hydroxycinnamic acid and nitrocellulose (Jensen et al., 1996) -and analyzed by MALDItime of flight mass spectrometry. The mass spectrometer (Bruker Reflex, Bruker-Franzen, Bermen, Germany) was equipped with delayed ion extraction. For peptide sequencing by nanoelectrospray mass spectrometry, the remaining product was extracted, concentrated and desalted on a 100 nl R2 Poros microcolumn, and eluted in 2ϫ0.5 μl of 60% methanol, 5% formic acid into a nanoelectrospray spraying needle as described . Analyses were performed on a triple quadrupole mass spectrometer (API III, PerkinElmer Sciex, Toronto, Canada). Database searches by peptide mass maps and by peptide sequence tags (Mann and Wilm, 1994) were performed with the program PeptideSearch using a comprehensive non-redundant database currently containing Ͼ230 000 entries.
Purification of the CCR4 complex
Yeast whole cell extracts were prepared by a modification of the method of Liu et al. (1997) in which 3ϫ buffer A [50 mM Tris-OAc, pH 7.9/ 150 mM KOAc/20% glycerol/0.2% Tween-20/2 mM β-mercaptoethanol (β-ME)/2 mM MgOAc plus protease inhibitors] was used to resuspend cell pellets (140 g of wet cells). The clear extract (120 ml) was applied to a 4 ml Ni 2ϩ -NTA column. The bound proteins were eluted in 250 mM imidazole in buffer A. The resulting Ni 2ϩ eluate (12 ml) was applied to a Mono Q HR5/5 column and the protein fractions were then eluted in a 20 ml linear 100-2000 mM gradient of KOAc in buffer B: 50 mM Tris-OAc, pH 7.9/100 mM KOAc/20% glycerol/0.02% Tween-20/1 mM β-ME/2 mM MgOAc/1 mM EDTA, plus protease inhibitors including 2 μl/ml of leupeptin (2 mg/ml), pepstatin A (1 mg/ml), chymostatin (5 mg/ml) and benzamidine (500 mM), and 10 μl/ml of 500 mM phenylmethylsulfonyl fluoride (PMSF). The fractions containing CCR4 and CAF1-6His were pooled (2 ml in total) and subjected to ultrafiltration using a Centricon 10 device (Amicon, MA). The concentrated protein sample (200 μl) was applied to a Superose 6 HR10/30 column equilibrated in buffer G (50 mM Tris-OAc, pH 7.9/150 mM KOAc/10% glycerol/ 0.02% Tween-20/1 mM dithiothreitol/1 mM EDTA/2 mM MgOAc) plus protease inhibitors. The protein fractions were collected as 0.5 ml/ fraction and stored at -80°C while part of the materials (10 μl for Ni 2ϩ -NTA and Mono Q eluate, and 25 μl for Superose 6 fractions) was subjected to immunoblot analysis using CCR4, CAF1 and NOT1 antibodies.
Gel filtration chromatography
The Superose 6 columns HR10/30 and HR16/50 were packed with Superose 6 media, prep grade, according to the manufacturer's instructions (Pharmacia). A molecular weight standard mixture was used to calibrate the Superose 6 columns. The calibration for the HR10/30 column in buffer G plus protease inhibitors was: exclusion volumn (blue dextran, 2000 kDa) at 10 ml; thyroglobulin (669 kDa) at 15 ml; bovine serum albumin (BSA) (66 kDa) at 17.5 ml. For the HR16/50 column, the calibration was: blue dextran at 38.6 ml; thyroglobulin at 59 ml; amylase (200 kDa) at 65 ml; BSA at 69 ml; carbonic anhydrase (29 kDa) at 72.7 ml.
To analyze the CCR4 complex using gel filtration chromatography, yeast whole cell extracts prepared from a 500 ml overnight glucosegrown culture in 3ϫ buffer A were first clarified by ultracentrifugation in a SW65 rotor at 45 000 r.p.m. for 60 min. Then 200 μl of the clear extracts were loaded onto a Superose 6 column. The resulting 1 ml fractions were subjected to Western blot analysis. For the DNase treatment experiments, yeast whole extracts were prepared in EDTAfree 3ϫ buffer A. After ultracentrifugation, 7.5 μl of DNase I (61.5 μg/ ml) were added to 1 ml of the clear extracts and the mixture was incubated at room temperature for 7 min. Then 200 μl of the mixture was analyzed on the Superose 6 column and 30 μl of the 1 ml fractions were subjected to immunoblot analysis.
